The m6A reader YTHDF1 facilitates nasopharyngeal carcinoma proliferation and migration via c-MYC

N6-methyladenosine (m6A), the most prevalent mRNA modification in eukaryotes, is critical for posttranscriptional regulation. The m6A reader YTH domain-containing family protein 1 (YTHDF1) acts as an oncogene in multiple malignancies, yet its specific roles and regulatory mechanisms in nasopharyngeal carcinoma (NPC) have not been fully elucidated. This study elucidates a novel epitranscriptional axis whereby YTHDF1 drives NPC progression via posttranscriptional regulation of c-MYC. Clinical analyses reveal YTHDF1 is overexpressed in a subset of NPC specimens, with high expression correlating with advanced stage and poor patient outcomes, supporting its potential as a prognostic biomarker. Functional assays demonstrate that YTHDF1 enhances NPC proliferation, migration, and invasion in vitro, while promoting tumor growth and metastasis in vivo. Mechanistically, m6A RNA immunoprecipitation sequencing identifies a conserved m6A modification peak within the 3' untranslated region near the stop codon of c-MYC mRNA, distinct from those reported in other malignancies, that is specifically recognized by YTHDF1, as validated by RIP-qPCR. Unlike its role in other cancers, where YTHDF1 primarily stabilizes c-MYC mRNA, in NPC it exerts dual posttranscriptional control: prolonging c-MYC mRNA half-life to enhance stability and increasing translational efficiency (confirmed by ribosome profiling) to elevate c-MYC protein levels, forming a coordinated regulatory network. Luciferase reporter assays confirm the functional necessity of this m6A site, as mutations abrogate YTHDF1-mediated regulation. Importantly, the m6A inhibitor STM2457 reverses YTHDF1-driven oncogenic phenotypes. These findings uncover a novel mechanism by which YTHDF1 regulates c-MYC through combined effects on mRNA stability and translation, advancing understanding of m6A-mediated oncogenesis and offering new insights into epitranscriptional control of cancer progression.

Authors

Institutions

Publication Details

Journal
Journal of Biological Chemistry
Published
2025-10-29
DOI
https://doi.org/10.1016/j.jbc.2025.110833
Citations
1
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The m6A reader YTHDF1 facilitates nasopharyngeal carcinoma proliferation and migration via c-MYC

Zhiwen Xiao, Tianliang Xia, Ping Han, Taowei Wu et al.
1 citations
Journal of Biological Chemistry
RNA modifications and cancer
0.81
article

The m6A reader YTHDF1 facilitates nasopharyngeal carcinoma proliferation and migration via c-MYC

Zhiwen Xiao, Tianliang Xia, Ping Han, Taowei Wu, Haicang Zeng, Qian Zhong, Xiaoming Huang, Yuchu Ye, Mu‐Sheng Zeng, Shibing Li
article en
1 citations

Abstract

N6-methyladenosine (m6A), the most prevalent mRNA modification in eukaryotes, is critical for posttranscriptional regulation. The m6A reader YTH domain-containing family protein 1 (YTHDF1) acts as an oncogene in multiple malignancies, yet its specific roles and regulatory mechanisms in nasopharyngeal carcinoma (NPC) have not been fully elucidated. This study elucidates a novel epitranscriptional axis whereby YTHDF1 drives NPC progression via posttranscriptional regulation of c-MYC. Clinical analyses reveal YTHDF1 is overexpressed in a subset of NPC specimens, with high expression correlating with advanced stage and poor patient outcomes, supporting its potential as a prognostic biomarker. Functional assays demonstrate that YTHDF1 enhances NPC proliferation, migration, and invasion in vitro, while promoting tumor growth and metastasis in vivo. Mechanistically, m6A RNA immunoprecipitation sequencing identifies a conserved m6A modification peak within the 3' untranslated region near the stop codon of c-MYC mRNA, distinct from those reported in other malignancies, that is specifically recognized by YTHDF1, as validated by RIP-qPCR. Unlike its role in other cancers, where YTHDF1 primarily stabilizes c-MYC mRNA, in NPC it exerts dual posttranscriptional control: prolonging c-MYC mRNA half-life to enhance stability and increasing translational efficiency (confirmed by ribosome profiling) to elevate c-MYC protein levels, forming a coordinated regulatory network. Luciferase reporter assays confirm the functional necessity of this m6A site, as mutations abrogate YTHDF1-mediated regulation. Importantly, the m6A inhibitor STM2457 reverses YTHDF1-driven oncogenic phenotypes. These findings uncover a novel mechanism by which YTHDF1 regulates c-MYC through combined effects on mRNA stability and translation, advancing understanding of m6A-mediated oncogenesis and offering new insights into epitranscriptional control of cancer progression.

Journal of Biological ChemistryVol. 301(12)
Sun Yat-sen University (CN), Sun Yat-sen Memorial Hospital (CN), Sun Yat-sen University Cancer Center (CN)
Openalex Percentile: Top 22%
RNA modifications and cancer
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.